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                                         INTRODUCTION 
Diabetes mellitus is a metabolic disorder of multiple etiologies, 
characterized by chronic hyperglycemia with disturbances of 
carbohydrate, fat, and protein metabolism resulting from defects in 
insulin secretion, insulin action, or both.  
Diabetes mellitus is generally classified into Type 1 and Type2 diabetes. 
Type1 DM is a complete or near complete insulin deficient state due 
to autoimmune destruction of pancreatic beta cell. Type 2 DM is due 
to insulin resistance rather than complete insulin deficient. Here, 
insulin resistance plays a major role.  
The prevalence of diabetes in India in 1970’s was 2.3% in urban and 
1.5% in rural areas, as shown by the multi-centric study. The 
prevalence has risen to 12% to 19% in urban areas and to 4% to 9% in 
rural areas in recent years. (2) 
A few population based studies in India indicate the prevalence of 
retinopathy to be 18% to 27%, overt nephropathy to be about 2.2%, 
peripheral vascular disease to be 6.3%, peripheral neuropathy to be 
26% and coronary artery disease to be about 21%.  (2) 
Diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic state 
(HHS) are dangerous manifestations of diabetes mellitus representing 
two extremes in the spectrum of uncontrolled diabetic state. DKA 
accounts for 14 percentages of all hospital admissions among diabetics 
and 16 percentages of all diabetes- related fatalities in India. (2) 
DKA occurs predominantly in those with type 1 diabetes. The basic 
defect in the pathogenesis of DKA is insulin deficiency. Glucagon is a 
counter regulatory hormone which facilitates gluconeogenesis 
mechanism, hence hyperglycemia will occur. The absolute insulin 
deficiency and hyperglycemia leads to synthesis of ketone bodies such 
as acetoacetate and beta hydroxyl butyrate from hepatocytes, hence 
ketosis will occur. 
The precipitating factors for pathogenesis of DKA are sub optimal insulin 
dose, insulin or oral antidiabetic drugs omission, respiratory tract 
infections, genito urinary tract infection, etc and Cerebrovascular 
accidents such as ischemic stroke and hemorrhagic stroke. 
Patients with DKA will present with symptoms of polyuria, thirst, 
reduction in weight, generalized tiredness, nausea, vomiting, blurring 
of vision, and abdominal discomfort. Patient may have a signs of 
dehydration, hypotension, cold extremities, peripheral cyanosis, 
tachycardia, air hunger (Kussmaul’s breathing), smell of acetone, 
hypothermia, confusion, drowsiness, and coma.  
Most patients with DKA recover when treated properly and if left 
untreated, patient may develop complications such as cerebral edema, 
thromboembolism, acute respiratory distress syndrome (ARDS), 
disseminated intra vascular coagulation (DIC), electrolyte 
abnormalities, myocardial infarction, infections, and acute circulatory 
failure.  
Early identification ketoacidosis and aggressive management with 
insulin, intra venous fluids and electrolytes replacement may change 
the outcome of the disease. 
 
 
 
 
 
                      
                               
 
                     AIMS AND OBJECTIVES 
 To study the age and sex distribution in DKA. 
 To evaluate the common presentation of Diabetic ketoacidosis. 
 To study the precipitating factors of diabetic ketoacidosis. 
 To study the role of duration of diabetes on DKA. 
 To study the incidence of DKA in poorly controlled diabetes by 
HbA1c level. 
 To study the correlation between serum bicarbonate level and mean 
duration of hospital stay in DKA patients. 
 To study the correlation of HbA1c level and mean duration of 
hospital stay in DKA patients. 
 To study the correlation of serum osmolality and its effect on 
mental status. 
 To study the outcome of DKA patients during treatment. 
 
 
 
 
 
                                
                               REVIEW OF LITERATURE 
                                    DIABETES MELLLITUS 
Diabetes is a metabolic disorder of various etiology characterized by 
prolonged hyperglycemia with disturbances of carbohydrate, fat, 
and protein metabolism. It is due to defective insulin secretion, 
insulin action, or both. The long term complications of diabetes 
are retinopathy with blindness, nephropathy that may lead to renal 
failure, neuropathy with foot ulcers, limb amputation, Charcot 
joints, and autonomic dysfunction like postural hypotension, 
sexual dysfunction etc.  The short term complications of diabetes 
mellitus are diabetic ketoacidosis and hyperosmolar 
hyperglycemic state (2). Both are life threatening complications in 
uncontrolled diabetes.          
                          DIAGNOSIS OF DIABETES MELLITUS 
Diabetes mellitus is diagnosed in a person with symptoms of 
polyuria, polydipsia, polyphagia, recurrent infections, unexplained 
weight loss and drowsiness, coma with random blood sugar of ≥ 
200 mg /dl. (2) 
 
Criteria for diagnosis of diabetes mellitus: 
1) HbA1c value more than or equal to 6.5 percentage. 
2) Fasting plasma glucose more than or equal to 126 mg/ dl.  
3) Random plasma glucose more than or equal to 200 mg/ dl with 
polyuria, polydipsia, and polyphagia. 
4) Glucose tolerance test is categorized in to three classes based 
on the fasting plasma glucose: 
1. Fasting plasma glucose less than 100 mg / dl is considered 
normal. 
2. Fasting plasma glucose ≥ 110 to ≤ 126 mg/ dl (venous plasma) 
is defined as impaired fasting glucose (IFG).(2) 
3. Fasting plasma glucose more than 126mg /dl warrants the 
further investigation to diagnose diabetes. 
4. Depending on the glucose tolerance test, impaired glucose 
tolerance (IGT) is defined as plasma glucose value between 140 
and 199 mg/ dl (2 hour after 75 grams oral glucose intake) and 
plasma glucose more than 200 mg / dl (2 hour after 75 grams oral 
glucose intake) is diagnosed as diabetes (2). Individuals with 
impaired fasting glucose and impaired glucose tolerance test are 
recently designated as ‘pre diabetes’ by the American Diabetes 
Association (ADA), are at substantial risk for developing type 2 
DM. (1) 
Regular exercises, diet advice regarding intake of balanced, low 
caloric diet, and avoidance of alcohol should be advised in pre 
diabetic individuals to avoid the further evaluation of diabetes in 
earlier. (11) 
Classification of diabetes mellitus: (2) 
Type1diabetes 
Type1 diabetes, previously called as juvenile diabetes, is usually 
identified in adolescents and younger age group. This is due to 
autoimmune etiology results in destruction of pancreatic beta cells 
and results in insulin deficient state. 
Type 2 diabetes 
Type 2 diabetes, previously called as adult onset diabetes. It is a 
common form of diabetes and has an insidious onset. Type 2 
patients are asymptomatic for many years. This is usually occur in 
adults, but can occur in childhood also. Weight loss is unusual 
unless the blood sugar is very high. Diabetic ketoacidosis is 
uncommon in type 2 DM. The incidence of familial inheritance is 
more common. 
Type2 diabetes begins with insulin resistance, and in the initial stage, 
there is counter regulatory hyperinsulinaemia. In later stage, the 
pancreas loses its capability to secrete required insulin in response 
to meal intake and results in clinical diabetes. 
Gestational diabetes 
It is state of carbohydrate intolerance resulting in hyperglycemia with 
onset or first diagnosed during pregnancy. Sometimes, 
carbohydrate intolerance may be unnoticed by the patient before 
antenatal period and diagnosed first time during pregnancy. In 
these types of diabetics, regular exercises and weight reduction in 
obese individual should be advised after delivery, to avoid type2 
diabetes in later period. 
In these diabetic patients, blood sugar should be estimated six to 
twelve week after postpartum period to identify the level of sugar 
control, and after that, it should be monitored every year  for life 
long period.(11) 
Among these types of diabetic women about 60 percentages of 
patients may become diabetic in next five to ten years. The risk of 
onset of type 2 diabetes is very high in this type. 
Latent autoimmune diabetes in adults ( LADA): 
In this type of diabetic patients have mild or moderate high blood 
sugar. In early period of the disease, these patients well respond to 
oral drugs, but in later periods, they will only respond to insulin 
therapy. These types of diabetics have auto antibodies and if they 
have more than one auto antibodies, they will become insulin 
dependent earlier.(11) 
Other types of diabetes   (2) 
The following other type of diabetes exist which occur due to: 
 Genetic defects in insulin action, 
 Genetic defects of the pancreatic beta cell 
 Diseases of the pancreas 
 Excess amounts of counter regulatory hormones 
 Infections 
 Rare autoimmune disorders, and 
 Genetic syndromes associated with diabetes. 
 
              Etiology and risk factors of DM 
Both type1 and type 2diabetes has genetic and environmental risk 
factors. Type1 diabetes is associated with HLA DR3 and DR4 
predisposition. Some possible mechanism of diet and viral 
infection triggering an autoimmune exposure resulting in 
destruction of pancreatic beta cell has been identified.(2) 
Type2 diabetes has strong genetic basis, as evidenced by its 
hereditary nature. But the major genes responsible for genetic 
inheritance have not been identified till date. Asian population was 
identified as more prone for racial predisposition. Increasing age, 
obesity, sedentary lifestyle, insulin resistance, and intrauterine 
adverse environment are other environmental factors associated in 
the pathogenesis. 
 Epidemiology of diabetes mellitus 
Type 1 diabetes 
The estimated global number of type 1 diabetes patients under the age 
of fourteen years is approximately 4.8 lakhs and approximately 
seventy six thousand children develop the disease annually. In 
developing countries like India, the available data is inadequate. 
(2) 
Type 2 diabetes 
The worldwide burden due to diabetes is mainly contributed by type 
2 DM which include eighty to ninety five percent of the all 
diabetic population. The disease prevalence is increasing 
explosively in the past three decades. It was estimated that about 
two eighty five million adults were affected by the disorder in 
2010 and its prevalence will increase to four thirty eight million in 
2030.(2) 
Type2 diabetes in children 
In Asian population, the onset of type 2 diabetes in younger age was 
increased in recent decades. In Indian children, microvascular 
diabetic complications were identified even at the time of 
diagnosis or within a short period after treatment.(2) 
type 1 diabetes mellitus -   pathogenesis 
The following factors are responsible for the pathogenesis of type 1 
diabetes 
 Genetic factors 
 Environmental triggers 
 Pancreatic beta cell destruction by various factors. 
Genetic factors 
In recent studies, familial clustering of type1 diabetes with siblings of 
type 1 patients having a risk of five percent and the risk of 
transmission from parents is about ten percent. 
HLA class I and II encoding genes are situated within the HLA 
region of chromosome 6. In some studies, the high incidence of 
type 1 diabetes with HLA-B8 and no or low incidence with HLA-
B7 were identified.  The risk was very high with HLA class II 
namely DR3 and DR4. DR2 was identified as protective. 
Environmental factors 
Viruses 
Viruses can affect pancreatic beta cells directly by cytolytic effects or 
indirectly triggering autoimmune response. In children with 
mumps virus infection develop antibodies against islet cell 
suggesting underlying autoimmune processes. Coxsakievirus B, 
cytomegalovirus, Epstein-Barr virus, and retro virus are all 
associated with type 1 diabetes. 
Dietary factors 
Type1 diabetes incidence was reported high in population were the 
drinking water contains high amount of nitrites and nitrates. 
Consumption of smoked and cured mutton also associated. Early 
exposure to cow milk in infants was another factor responsible for 
high incidence of type 1 diabetes. Vitamin D supplementation was 
identified as protective against type1 diabetes. 
 
Auto immune damage to beta cells 
Fifty to ninety percent of type1 diabetes patients had antibodies 
against islet cells, and glutamic acid decorboxylase. Type1 
diabetes is associated with autoimmune diseases like Hashimoto’s 
thyroiditis, Grave’s disease and celiac disease, etc. 
Pathogenesis of type 2 diabetes 
The pathogenesis of type 2 diabetes is mainly due to two important 
factors. These are 
1) Peripheral insulin resistance and Hepatic insulin resistance 
2) Impaired beta cell function( insulin secretory defect) 
Peripheral and hepatic insulin resistance 
It was first described in obese type2 patients. Even though, the insulin 
level is high in type 2 diabetic patients, there is low glucose 
utilization and insulin inaction in the adipose tissue, muscle and 
hepatic cells. The molecular mechanism underlying the insulin 
resistance is prolonged hyperglycemia, produces glucotoxicity, 
due to failure to enhance hexosamine pathway, leading to 
increased glucosamine levels. This increased glucosamine level 
produce insulin resistance in adipose tissue and other tissues.  
Another mechanism is prolonged hyperglycemia will down regulate 
the insulin receptor and further worsen insulin resistance. The 
glucocorticoid induced insulin resistance is also identified as a 
pathogenic factor. 
Insulin secretory defects 
In a normal person, about eighteen to thirty units of insulin is secreted 
daily and about fifty percent is removed from the liver for local 
action during its first passage. In type 2 diabetes, both rapid meal 
related insulin secretion which occurs within 30 minutes after 
meal, and post meal insulin secretion which occurs for the 2 hour 
period are impaired. The molecular mechanism responsible for 
these changes is due to over expression of hexokinase genes as 
compared to glucokinase gene. 
The beta cell mass is minimally reduced at the time diagnosis and the 
disease progress to several years, the beta cell mass declines 
further due to fibrillary amylin deposition in the beta cells. 
In about ten percent of type 1 diabetics, the beta cell failure is due to 
auto immune process. This is known as latent autoimmune 
diabetes of adults. 
Incretin effect in the pathogenesis of type2 diabetes 
The gastrointestinal tract secretes the hormones called incretins. This 
includes glucagon like peptide and glucose dependent 
insulinotropic peptide. These hormones are responsible for the 
increased secretion of insulin after oral glucose intake. This is 
known as incretin effect. This effect is blunted in type 2 diabetes. 
Other mechanism is high glucagon level after meal also responsible 
for hyperglycemia. 
Hypothalamic neurons and neurotransmitters are identified in 
pathogenesis type 2 diabetes. The first phase of insulin secretion is 
mediated through these pathways. In obese and insulin resistant 
subjects, after the glucose intake, the elevated plasma insulin 
levels are unable to produce inhibitory response in these nuclei. 
Role of kidney in pathogenesis of type2 diabetes 
In a normal individual, about 160 gram of glucose is filtered in the 
glomerular filtrate. About ninety percent of it is reabsorbed in 
PCT by glucose transporter called SGLT2. Another ten percent of 
the filtered glucose is absorbed in the descending part of proximal 
tubule by glucose transporter SGLT1. In type2 diabetes, the 
SGLT2 is increased up to four times of normal. This leads to 
increased glucose resorption and hyperglycemia. 
HbA1c level and its importance 
HbA1c level is a glycosylated hemoglobin level in plasma and its 
level increases with poor control of blood sugar in diabetic 
individuals. HbA1c level and its interpretation 
Normal        =         less than 5.7 percentage 
Pre-diabetes =         5.7 to 6.4 percentage 
Diabetes      =         6.5 percentage and more 
Diagnosis based on HbA1c needs confirmation by routine blood 
sugar methods. In asymptomatic individuals with HbA1c level 
more than 6.5 percent, if pre prandial blood sugar >126 mg/dl or 
random blood sugar >200 mg/ dl, diagnosis of diabetes is 
confirmed. 
The advantage of HbA1c measurement: 
1) Patient need not to remain fasting. 
2) HbA1c level is a measure of long- term plasma glucose 
control, rather than present plasma glucose. 
3) Errors due to other factors affecting HbA1c like 
haemoglobinopathies can be minimised by comparing plasma 
glucose level.  
In patients with high HbA1c level, the metabolic control is poor, 
leads to chronic hyperglycemia. In this situation, single dose of 
insulin or drug omission, and infection may trigger the 
development of ketoacidosis or hyperosmolar hyperglycemic state 
in diabetes. 
The lack of availability of HbA1c test in remote areas, the high cost 
of the test, and faulty standardization techniques are certain 
limitations in using this test. Non glycemic factors modifying 
HbA1c level such as anemia, polycythemia, haemoglobinopathies 
and uremia are other limitations of this test. 
                DIABETIC KETOACODOSIS  
Diabetic ketoacidosis (DKA) and Hyperosmolar hyperglycemic state 
(HHS) represent two distinct metabolic derangements manifested 
by insulin deficiency and severe hyperglycemia.  
DKA occurs in the setting of more severe insulin deficiency, and low 
circulating levels of insulin leads not only to hyperglycemia and 
dehydration but also to the production of ketone bodies and 
acidosis.  
HHS occurs when insulin deficiency relative to insulin requirements 
causes hyperglycemia, which in turn leads to dehydration, 
resulting in a severe hyperosmolar state. 
To diagnose the DKA, the following  are essential: 
1) High blood sugar ( blood sugar more than 250 mg / dl )(13) 
2) Ketosis 
3) Acidemia ( pH less than 7.3 ) 
Sometimes, both diabetic ketoacidosis and hyperosmolar 
hyperglycemic state can occur simultaneously. 
               EPIDEMIOLOGY 
In one of the largest studies of the epidemiology of DKA, Faich et al 
reported an annual incidence of DKA in Rhode Island of 46 cases 
per 10,000 persons with diabetes and 1.4 cases per 10,000 persons 
in the general population. (13) 
More than twenty percent of patients admitted for DKA had 
previously undiagnosed diabetes. Another fifteen percent of 
admissions were of patients with multiple admissions for DKA. 
Several studies reported that the average age of patients admitted for 
DKA was 40 to 50 years, but that the risk decreased with age. 
Some studies have reported a female predominance possibly because 
young women were more likely to have repeated episodes of 
DKA. (13) 
DKA is the one of the major cause of death in diabetic individuals, 
younger than 24 year old, accounting for about one half of the 
deaths in this population group. Before the discovery of insulin in 
1921, the mortality due to DKA was virtually 100%. By 1932, 
mortality decreased to 29%. 
 By the 1950s, the reported mortality was 15%, with the improvement 
credited primarily to the widespread use of antibiotics, the intra 
venous potassium replacement, and the use of norepinephrine for 
blood pressure support. 
 In recent studies, mortality rate was ranging from 2.5% to 9% 
among patients admitted with DKA have been reported. 
Mortality among patients with DKA has been related to age, 
degree of hyperosmolarity, and severity of azotemia. 
PATHOPHYSIOLOGY OF DKA: 
In both diabetic ketoacidosis and hyperosmolar hyperglycemic stare, 
relative insulin deficiency is the critical underlying defect. In both 
DKA and HHS, sub optimal level of insulin in peripheral 
circulation relative to insulin requirements results in 
hyperglycemia, further results in total body water deficit. When 
insulin deficient state becomes severe, ketoacidosis will occur. 
Type 2 diabetics develop ketoacidosis even without insulin deficient 
state due to presence of insulin resistance. Insulin resistance is 
mediated by several factors, including the pathophysiology of type 
2 diabetes and increase in the level of counter regulatory 
hormones, including cortisol, glucagon, epinephrine, and growth 
hormone. 
Any physiologic stress in the patient with type 1 diabetes may result 
in DKA, due to elevated levels of counter regulatory hormones. 
                                 
 
 
 
                              
 
 
                           insulin Deficiency 
             ↓                                                                       ↓  
   
Increased lipolysis                                               hyperglycemia 
            ↓                                                                         ↓              
Increased ketogenesis                                Osmotic  Diuresis 
           ↓                                                                          ↓ 
     
Ketoacidosis                                             Hyperosmolarity 
           ↓                                                                         ↓ 
  Pure diabetic  
 Ketoacidosis                 ↔              Pure Hyperosmolar state. 
 
 
The role of counter regulatory hormones in the pathogenesis of 
diabetic ketoacidosis: 
1) Increased secretion epinephrine, cortisol, and growth hormone 
inhibits the insulin facilitated glucose utilization in the 
muscles, there by hyperglycemia and ketosis. 
2) High levels of glucagon and other hormones results in 
activation gluconeogenesis mechanism and glycogen 
breakdown mechanism in the hepatocytes, thereby 
hyperglycemia will occur. 
3) Epinephrine and growth hormone facilitate the lipid breakdown 
mechanism in the fat tissues. 
4) Epinephrine and growth hormone may have direct effect on 
inhibition of residual insulin secretion. 
In diabetic ketoacidosis, the relative or complete insulin deficiency 
and counter regulatory hormone like glucagon excess leads to 
gluconeogenesis and ketone body synthesis from the liver. The 
marked elevation in free fatty acid release from the adipocytes 
secondary to reduced insulin level and increased ketone body 
synthesis (acetoacetate and beta hydroxybutyrate) from the liver 
through activation of carnitine palmitoyltransferase I secondary to 
high glucagon level, results in ketosis.  This carnitine 
palmitoyltransferase I enzyme is responsible for the fatty acid 
transport into the mitochondria. In mitochondria, beta oxidation 
and conversion to ketone bodies occurs. These ketone bodies have 
a low pH and result in metabolic acidosis. 
In Hyperosmolar hyperglycemic state, some amount of insulin is 
available for ketosis prevention but the amount of available insulin 
to control hyperglycemia is not   optimum, is the reason for 
absence of ketosis. Hyperosmolar state itself decreases the amount 
of free fatty acids available for ketogenesis. In addition, low 
counter regulatory hormones found in hyperosmolar state also 
prevent the ketosis formation. 
Gerich et al studied the effects of infusing counter regulatory 
hormones in to insulin-dependent patients. Neither glucagon nor 
did growth hormone infusion produce an elevation in ketone 
bodies until insulin was withdrawn. 
The hyperglycemia causes a profound osmotic diuresis leading to 
dehydration and electrolyte loss, particularly of sodium and 
potassium. 
In an adult diabetic ketoacidosis patient, approximately about six 
litters of water, 500 mmols of sodium, 400 mmols of chloride, and 
350 mmols of potassium will be lost. 
About half the deficit of total body water is derived from the 
intracellular compartment and occurs comparatively early in the 
development of acidosis with relatively few clinical features; the 
remainder represents loss of extracellular fluid sustained largely in 
the later stages. It is at this time that marked contraction of the 
size of the extracellular space occurs, with haemoconcentration, a 
decreased blood volume, and finally a fall in blood pressure with 
associated renal ischemia and oliguria.  
Every patient with diabetic ketoacidosis will be in a state of 
potassium-depleted, but the plasma concentration of potassium 
gives very little indication of the total body deficit.  
Plasma potassium may even be raised initially due to disproportionate 
loss of water and catabolism of protein and glycogen. However, 
soon after insulin treatment is started there is likely to be a 
precipitous fall in the plasma potassium due to dilution of 
extracellular potassium by administration of intravenous fluids, 
the movement of potassium into cells as a result of treatment with 
insulin, and the continuing renal loss of potassium.  
The sodium concentration is increased due to hyperglycemia in 
ketoacidosis. So, in DKA, the normal sodium level denotes that 
water deficit is much severe.  
The serum osmolality is measured by = 2× Na   + Blood sugar /18 + 
Blood urea / 5.6.             
The normal serum osmolality is between 285- 295 mOsm/ kg. The 
linear relationship was noted between the patient’s serum 
osmolality and their mental alteration in several studies.  Serum 
osmolality can be increased mildly in DKA.  
 
 
 
 
 
  
              The differentiating features between diabetic ketoacidosis 
and  
    Hyperosmolar state 
  Diabetic 
ketoaci
dosis 
Hyperosmola
r 
hyperglyc
emic state 
1 Blood 
sugar 
More than 
250 mg 
/dl 
More than 
600 mg / 
dl 
2 pH Less than 
7.2 
More than 
7.4 
3 Bicarbonat
e level 
Less than 
15 
mEq/ l 
More than 15 
mEq/ l 
4 Serum/ 
urinary 
ketone 
Positive Negative 
5 Serum 
osmola
lity 
Variable More than 
320mOsm
/kg 
6 Anion gap More than 
or 
equal to 
13 
Less than 12 
7 Mental 
confusi
on 
Depends 
on 
severity 
Stupor or 
coma is 
common 
 
 
 During ketone body production, hydroxybutyrate is produced more 
than three times of acetoacetate. Nitroprusside reagent method 
detects acetoacetate in urine. But, measurement of 
hydroxybutyrate in blood is ideal method, because it denotes the 
real ketone body level in the blood. 
 
Precipitating factors  in DKA are 
 Sub optimal insulin dose.(1,2,3,13) 
 Insulin or anti diabetic drug omission.  
 Respiratory tract infection, urinary tract infection, wound 
infection etc. 
 Cerebrovascular accidents such as ischemic stroke and 
hemorrhagic stroke 
 Myocardial infarction 
 Uncontrolled diabetes. 
 Antenatal period. 
 
Complete omission or inadequate administration of insulin by the 
patient may precipitate DKA. Patients using insulin infusion pump 
devices with short-acting insulin may develop DKA within few 
hours, if the fault occurs in devices.   
About 20- 40 percent of DKA is precipitated by infection. Among the 
infections, urinary tract infection and respiratory tract infection are 
more common. (1, 3) 
Cerebrovascular accidents, myocardial infarction, pancreatitis, and 
alcohol abuse are rare causes of precipitating factors, account for 
about 10 % of all cases of DKA. (1, 2, 3, 13). 
In adolescent population, the most common precipitating cause is 
omission of insulin, because many of whom utilize this as an 
opportunity to control weight. 
Drugs also may precipitate DKA, most offending drugs are 
corticosteroids, sympathomimetic drugs ( dobutamine and 
terbutaline), and thiazide diuretics. (3) 
 Recently, newer antipsychotic drugs like clozapine, olanzapine, and 
risperidone have been identified as the cause for hyperglycemia 
and DKA. Treatment with interferon-alpha and ribavirin has been 
associated with the development of DKA in a patient with 
hepatitis C.  
In some patients, the precipitating events could not be identified. 
 
Clinical features: 
DKA may be the initial presentation to the hospital to a diagnosis of 
type1 diabetes and even some with cases of type 2 diabetes. But, 
DKA is common in patients who are already having diabetes. The 
presenting symptoms of DKA are as follows: 
 Polyuria (1, 3) 
 Thirst 
 Wight loss  
 Weakness 
 Nausea, vomiting 
 Leg cramps 
 Blurred vision  
 Abdominal pain 
 Shortness of breath 
 Altered sensorium 
The presenting signs are as follows 
 Dehydration( 1,3) 
 Hypotension (postural or supine ) 
 Cold extremities  
 Peripheral cyanosis 
 Tachycardia 
 Air hunger (Kussmaul breathing) 
 Smell of acetone 
 Hypothermia 
 Lethargy, confusion, drowsiness 
 Coma  
Nausea and vomiting are most common presentation. So the lab 
investigations for ketosis should be obtained for patients 
presenting with the above symptoms. In some patients, abdominal 
tenderness may mimic like acute abdomen or bowel perforation. 
High blood sugar leads to increased amount glucose leak in the urine, 
may produce dehydration and increased heart rate. 
Hypotension is due to decrease in blood volume and dilatation of 
vessels. 
Kussmaul respirations are due to low pH and high amount of ketone 
bodies. 
 Hyperglycemia induces the cerebral edema, results in lethargy, 
confusion, finally coma and death. Cerebral edema, is one of the 
dangerous complication, is more common in 0- 12 years. 
Diagnosis 
Laboratory investigations 
In patients with symptoms and signs of DKA, the following 
investigations should be ordered for diagnosis. (13) 
 Complete haemogram 
 Plasma glucose 
 Serum and urine ketones 
 Serum electrolytes 
 Blood urea  
 S.Creatinine 
 Arterial blood gas  
 Electrocardiogram 
 Cultures of urine, blood and throat – if clinically indicated 
 Chest X ray- if respiratory infection is under suspicion 
 HbA1c (glycosylated hemoglobin)- may provide information 
about the degree of metabolic control. 
In patients with severe dehydration, serum Na level is elevated. The 
acidosis leads to a shift of intracellular potassium to extracellular. 
So, serum potassium level may be high at presentation. When 
treatment is started, potassium replacement is required, because 
resolution of acidosis will lead to cellular reuptake of potassium 
and hypokalemia. When potassium value at the time admission 
more than 5.5mEq/l , or  due other associated renal injury, 
potassium infusion is not warranted. If the hypokalemia during 
insulin therapy is not corrected, may result in cardiac arrhythmia. 
Patient’s serum osmolality values are sometimes responsible for their 
mental confusion / coma. If the patient is presenting with coma 
and altered sensorium, with osmolality < 320 mOsm/kg, 
possibilities of other causes of com should be suspected. 
Without the presence of pancreatitis, the pancreatic enzymes can be 
elevated. Increase in pancreatic enzymes more than three times of 
normal do not confirm a diagnosis of pancreatitis in these 
situations. Sometimes, coexisting pancreatitis may be present in 
10% - 15% of patients with DKA. 
Leukocytosis may occur in DKA in the absence of infection. The 
mechanism of leukocytosis is not clearly understood. 
Differential diagnosis 
Other causes of ketoacidosis need to be considered when diabetic 
patient present with ketosis. These include 
 Starvation ketosis  
 Alcoholic ketoacidosis 
 Uremia in chronic kidney disease 
 Drugs producing metabolic acidosis  
 
 
Treatment of diabetic ketoacidosis 
Treatment of DKA is based on correcting the underlying the 
pathophysiologic defects, correcting the fluid and electrolyte 
imbalance, normalizing the blood glucose, correcting the acid base 
disturbance, and treating the precipitating cause. 
              
           Fluids 
             Normal saline should be given at rate of 15 ml per kilogram 
per hour and followed by 0.45 percent normal saline at a rate of 250 
ml per hour. When blood sugar reaches below 250mg/dl, 5 percent 
dextrose solution should be changed. 
Guidelines for insulin management 
 Regular insulin 10 U i.v bolus (1,13) 
 Followed by regular insulin at a dose of 0.1 Units per kilogram    
per hour should be given in infusion. 
 Increase insulin 1 U per hour every 1-2 hour if less than 10 % 
decrease in blood sugar. 
 When blood sugar comes down to less than 250 mg/dl, the 
insulin dose should be reduced 1 to 2 units per hour. 
 Maintain blood sugar between 140 – 180 mg/ dl. 
 When the blood sugar comes down below 80 mg / dl, insulin 
should be stopped for sometimes. 
 If the blood sugar level is below 100 mg/dl for long time, 
dextrose containing fluids should be given. 
 Once the patient is able to eat, change to subcutaneous insulin. 
Overlap short-acting insulin s.c and continue i.v infusion for 1-2 
hours.  
For patients with previous insulin- return to previous dose of insulin. 
For patients with newly diagnosed diabetes: full dose s.c insulin 
based on 0.6 U/kg per day. (1,13) 
              Replacement of potassium 
When plasma k+ level is < 5-5.2 mEq/ Littre, 10 mEq of potassium is 
replaced per hour. If the K+ less than 3.5 mEq / Litre, 40- 80 mEq 
of potassium should be replaced. If the initial serum potassium is 
> 5.2 mmol/Littre, potassium should not be given. Once the K+ 
level come down to normal limits, K+ replacement can be given. 
(13) 
               Bicarbonate supplementation 
In most situations, treatment with insulin results in resolution of the 
acid-base abnormality. No studies to date showed the benefits of 
bicarbonates replacement. So, treatment with bicarbonate should 
be considered only in patients whose pH is < 7.0. It should be 
given intravenously in a dose of 100 ml of Sod. Bicarbonate in 
500 ml saline; 200 ml per hour. 
During management, capillary glucose should be monitored every 1-2 
hours. Serum electrolytes especially potassium, bicarbonate 
should be measured every 4 hours for first 24 hours. 
In recent days, early identification of DKA by lab investigation, and 
prompt initiation of treatment in intensive care units has reduced 
the mortality rate to less than 1 percentage in developed countries. 
But, in developing countries, still the mortality rate is high. 
Phosphates and magnesium: 
In DKA patients, phosphate and magnesium level are decreased and 
further reduction may occur during insulin treatment. But, usually, 
these electrolytes are not given, when the patient takes oral diet. If 
the phosphate level is low, and the patient is not taking oral diet, 
potassium phosphate can be given. (11,13) 
If magnesium level found low level in DKA patient, who developed 
cardiac arrhythmias, magnesium sulfate can be given. Otherwise, 
routine supplementation is not needed. 
Complications of diabetic ketoacidosis: 
Metabolic complications occurring while treatments are electrolyte 
abnormalities (hypokalemia / hyperkalemia), sudden 
hypoglycemia, and rarely hypocalcaemia. 
Infection may be aggravated due to uncontrolled diabetes during 
treatment. 
Hypovolemic shock can occur due to severe dehydration and sepsis. 
Vascular complications like cerebral thromboembolism can occur due 
to dehydration. 
Acute pulmonary edema of non cardiac etiology can occur due excess 
fluid replacement, especially in patients with associated co morbid 
illness. 
Increased intracranial tension and cerebral edema can occur if 
acidosis is severe. 
Lactic acidosis may be precipitated in some DKA patients. 
If insulin is stopped earlier before the disappearance of ketoacidosis, 
rebound ketoacidosis may occur and may worsen the outcome of 
the disease. 
Prevention aspects in DKA:  
Diabetic patient should be educated about the importance and 
seriousness of the disease. 
Self monitoring of blood sugar is advised all diabetic, to achieve a 
target blood sugar. Especially who are on insulin, should be 
advised self blood sugar monitoring twice a day.  
Continuous blood sugar monitoring in patients with wide variability 
in blood sugar level, can be advised. 
HbA1c level can be monitored once in three months, to know the 
long term blood sugar control. 
Routine monitoring of urine acetone in type1 patients with the use of 
ketostix can be advised for earlier identification of DKA.  (11) 
 
 
Review of  other relative studies in  diabetic ketoacidosis: 
Daad Hassan Akbar conducted a study in King Abdul Aziz university 
hospital, Saudi Arabia, in 102 Diabetic ketoacidosis patients. In 
this study, 75 percentages of patients were type1 diabetes and 25 
percentages of patients were type 2 diabetes. Male: female sex 
ratio was 2.1: 1. In this study, poor compliance and sub optimal 
insulin dosage was the major precipitating factors (56 
percentages). The major presenting problem in this study was 
nausea and vomiting (89 percentages).  
Berhane Seyonum, MD was conducted a study in University school 
of Medicine, Detroit, among the 847 DKA patients. In this study 
17 percentage of DKA patients were newly diagnosed diabetes. 
Among these 847 patients, 311 patients (36%) were repeatedly 
admitted for diabetic ketoacidosis. Males were   more affected 
than females in a ratio of 2:1. 59 percentages of patients were 
admitted for discontinuation of treatment and infection was the 
next cause for development of ketosis (38 percentages). The 
average mean duration of hospital stay in this study was 6.7 days. 
Among these study population, the mortality rate was 6%.  
C Rajasoorya and his colleagues had done a study among 33 DKA 
patients in Department of medicine, Alexander hospital, 
Singapore. In this study, 18 percentages were newly detected 
diabetes. 52 percentages of the patients were presented with 
polyuria and polydipsia. In this study the mean serum osmolality 
value was correlated in patients who presented with confused state 
or coma and found that it was higher in patients with confused 
state than in patients presented with other symptoms. Among the 
precipitating causes, infection remained the primary cause for 
development of DKA. The mortality rate in this study was 10 
percentages. 
Ramaswamy Ganesh and his colleagues did a comparison study 
among 21 children in Department of pediatrics, Kalawati saran 
hospital, Delhi. Among these 21 patients 13 were boys and 8 were 
girls (sex ratio was 1.4: 1).  He observed that the HbA1c level was 
very high in all 21 patients and 17 percentages of patients were 
presented with polyuria. 
Balasubramanyam  A et al, from Department of Medicine, Baylor 
college of Medicine, Houston had done a cross sectional study in 
141 DKA patients. Among these patients, 53 % were type 
1diabetes, 39 % were type 2 diabetes and 8 % of the patients were 
could not be identified as either type1or type 2 DM. Type 1 
diabetes were relatively lean and mean age of diagnosis of 
diabetes in type 1 patients was less than 40 years. 
In Department of Endocrinology, Post graduate institute, Chandigarh, 
Matoo V K and his colleagues, did a prospective study among 143 
DKA patients over a period of 6 years. The result showed that 48 
patients were newly diagnosed as diabetes with ketoacidosis. 
Among these 143 patients, 42 patients were presented with 
infection (30 percentages).  During this study, 34 patients died due 
to DKA complications (23.7 percentages). The mortality rate was 
very high in this study.  
Qari FA had done a study in university hospital, Saudi Arabia, among 
the 68 diabetic ketoacidosis patients. In his study, he reported that 
poor compliance was the major factor for the development of 
DKA. The mortality rate in his study was 2.9 percent. 
Tahboub I et al, in Jordan did a prospective study in DKA over four 
years in 147 patients, and he found that 89 patients were male and 
78 patients were female. Twenty one percentages of patients were 
newly detected diabetics in his study. Most the patients developed 
DKA due to non compliance. The mortality rate due to diabetic 
ketoacidosis in that institution was about 4.8 percentages. 
Habib HS did a study in 2005, at king university, Jeddah, among the 
172 children. Among these patients, 101 were female children and 
71 were male children. In this study, DKA incidences were more 
in female children. Among the study population, 21 children were 
having altered consciousness. He correlated the patient’s acidosis 
level and their mental confusion and presentation with coma. He 
reported that, the patient’s acidosis level at the time of admission 
was significantly correlated with their mental confusion state. 
Snogaard O et all had done a study in 1989, among the 175 diabetic 
patients admitted with ketoacidosis. In this study, he observed that 
diabetic patients were repeatedly getting admission for 
ketoacidosis and the recurrence rate; he reported was around 3.4 
percentages.  
 Akhter khan et al conducted a study, in Aga khan university, among 
the 62 patients of DKA. Among these patients, 44 (71 
percentages) were type 1 diabetics and 18 (29 percentages) were 
type 2diabetics. Infection was the primary cause to precipitate 
diabetes about 45.2 percentages. He correlated the neurological 
status with patient’s random blood sugar mean, pH level and 
serum osmolality level. He observed that the mental alteration in 
patients who were having high random blood sugar, low pH and 
high serum osmolality values at a statistically significant level.  
  
 
 
 
 
                          
 
 
 
 
 
  
 
                        MATERIALS AND METHOD 
  Study design: prospective study. 
 Selection of study population:  
 This cross sectional study includes 50 patients with Diabetic 
ketoacidosis admitted in medicine ward and Intensive care unit in 
Government Rajaji Hospital, Madurai.  
Type 1 and type 2 diabetic patients of both sexes were included in the 
study. Both symptomatic and asymptomatic patients were included 
in the study.  
The study includes both newly detected diabetic ketoacidosis patients 
as well as patients who were already receiving diabetic treatment, 
developing diabetic ketoacidosis. The written informed consent was 
obtained from each patient or his / her relatives about the study. 
Period of study: 9 months. 
Collaborative departments: 
1. Department of Diabetology, GRH, Madurai. 
2. Department of Biochemistry, GRH, Madurai. 
 Biochemical investigations: 
The initial biochemical investigations such as Random blood sugar, 
Serum Elecrolytes (Sodium, potassium, and bicarbonate), Urine 
Acetone, Blood urea, and Serum Creatinine were measured to 
confirm the diagnosis. 
Urine ketone bodies were identified by Rothera’s nitroprusside test. 
This test procedure was as follows, 
1) Preparing the reagent by mixing 10g ammonium sulfate, 0.3g 
sodium nitroprusside and 5g anhydrous sodium carbonate. 
2) 0.5 – 1.0g of this reagent was taken in to a test tube and a drop of 
fresh urine was added. 
3) The color change after 1 minute was observed. Under alkaline 
condition, ketone bodies react with nitroprusside to give a purple 
color ring.  
HbA1c level was measured by automated analyzer method. 
The presenting symptoms such as Nausea/vomiting, mental 
confusion, Thirst / polyuria, Wight loss / weakness, abdominal pain, 
Coma and without symptoms were elicited by history and clinical 
examination to evaluate the common mode of presentation. 
The precipitating factors for the diabetic ketoacidosis such as,   in 
adequate insulin administration, Poor patient compliance, Infection, 
Infarction, and without obvious precipitating cause were assessed by 
history and clinical examination to find out the common 
precipitating factor. 
Duration of diabetes: 
The duration of diabetes is recorded for each patient by history and 
available records. According to the duration of diabetes, the study 
group is divided in to four groups. 
1) 0 – 5 years of duration of diabetes. 
2) 6 – 10 years of duration of diabetes. 
3) 11 – 15 years of duration of diabetes. 
4) More than 15 years of duration of diabetes.  
These 4 four groups were compared to evaluate, whether the 
incidence of DKA increases with increased duration of diabetes. 
HbA1c level: 
In all the study patients, HbA1c level was measured by automated 
analyzer method    to find out the past 3 month duration of glycemic 
control. In this study DKA patients were divided in to four groups 
based on the HbA1c level. 
Group I – HbA1c level between 6.5-7.5 % 
Group II- HbA1c level between 7.6-8.5% 
Group III- HbA1c level between 8.6-9.5% 
Group IV - HbA1c level more than 9.6 %  
These four groups were compared to find out the role of long 
standing poor glycemic control for development of diabetic 
ketoacidosis. 
In these four groups the mean duration of hospital stay was calculated 
separately to find the effect of HbA1c level in outcome of the DKA 
patients. 
Serum osmolality: 
The serum Osmolality was calculated from the following formula: 
2 × Na + Blood sugar /18 + Blood urea / 5.6.  
The normal range of serum osmolality is 285-295 mOsm/kg. Studies 
on serum osmolality and mental alteration have established a 
positive linear relationship between osmolality and mental alteration. 
In this study, study groups were divided in to two groups according to 
their serum osmolality. 
 Group A:  Serum Osmolality less than 320 mOsm/ kg 
Group B:  Serum Osmolality more than 320 mOsm/kg 
In each group, number of patients had the altered level of 
consciousness, and coma during presentation or during treatment 
was counted. These values were compared among these groups to 
find out the relationship between the serum Osmolality and mental 
alteration and outcome in DKA patients. 
Serum bicarbonate level: 
In this study, patients were divided in to three groups according to 
their serum bicarbonate values. 
Group I =     serum bicarbonate level between 16-20mEq/l. 
Group II =   serum bicarbonate level between 11-15mEq/l. 
 Group III = serum bicarbonate level ≤ 10mEq/l. 
In these three groups, the mean duration of hospital stay was 
calculated separately and these values were compared to find the 
correlation of serum of serum bicarbonate level and outcome of the 
patient. 
 
   
      
 
  
 
 
 
  
 
 
 
 
                               
 
                 Results and observation of the study 
Age distribution: 
Among these 50 DKA patients, 7 patients were in 13- 20 years age group 
(mean age =16.2 and 14%), 13 patients were in 21- 30 years age 
group (mean age =26.02 and 26%), 11 patients were in 31-40 years 
age group ( mean age = 33.14, and 22 %), 6 patients were in 41- 50 
years age group ( mean age = 45.08 and 12%), 8 patients were in 51 -
60 years age group ( mean age = 54.04 and 16 %) and 5 patients were 
in more than 60 years age group ( mean age = 68.20 and 10%). These 
data reveal that the incidence of DKA was higher in 21- 40 years in 
an adult population. 
(Table-1and chart-1) 
Sex distribution: 
In this study, 36 patients were male (72%) and 14 patients were female 
(28%). This result shows that DKA is common in male population 
compare to female population. (Table-2 and Chart-2) 
 
 
Incidence of DKA among type1 and type 2 diabetes patients: 
In our study, among these 50 patients, 31 patients were belongs to type 1 
diabetes and 19 patients were belongs to type 2 diabetes. It clearly 
shows that the incidence of diabetic ketoacidosis was more common 
in type 1 patients. (Table- 3 and chart- 3) 
Duration of diabetes and incidence of DKA: 
In this study, 22 patients had 0-5 year duration of diabetes, 14 patients 
had 6- 10 year duration, 12 patients had 11- 15 year duration , and 
only 2 patients had more than 15 year duration of diabetes. This result 
shows that the more duration of diabetes and incidence of Diabetic 
ketoacidosis didn’t have the correlation. (Table-4 and Chart-4) 
Presentation of DKA patients: 
Among these 50 patients, 13 patients were presented with symptoms of 
thirst and dehydration (26%), 11 patients were presented with mental 
confusion(22%), 7 patients were presented with nausea and vomiting 
(14%), 3 patients were presented with hypotension and cold 
extremities (6%), 2 patients were presented with shortness of breath 
(4%), 3 patients were presented with abdominal pain (6%), 3 patients 
were presented with lethargy (6%), 2 patients presented with 
palpitation and tachycardia (4%), 2 patients were presented with 
coma (4% ), and 4 patients were diagnosed  incidentally with high 
blood sugar with no symptoms(8% ). This result shows that the thirst 
and dehydration, mental confusion, and nausea and vomiting were the 
common presenting problems in diabetic ketoacidosis.  (Table-5 and 
Chart-5) 
Precipitating factors identified in DKA patients: 
In our study, infections such as urinary tract, respiratory tract, and 
wound infection were identified in 17 patients as a precipitating cause 
(34%), insulin or drug omission was the cause in 14 patients (28%), 
inadequate insulin administration was the cause in 7 patients (14%), 
cerebral infarction was the cause in 2 patients (4%), and in 8 subjects, 
no cause was identified for precipitation DKA (16%). Two patients 
were newly diagnosed as diabetes and the initial presentation was 
DKA (4%). (Table-6 and Chart6) 
DKA incidence and correlation with HbA1c level: 
In this study, 5 patients had HbA1c value of 6.5-7.5 (10%), 9 subjects 
had HbA1c level of 7.6-8.5 (18%), 12 patients had HbA1c level of 
8.6-9.5 (24%), and 24 patients were having HbA1c value more than 
9.5 (48%). These values shows that incidence of diabetic ketoacidosis 
was high in diabetic patients who were having high HbA1c level. 
(Table-7 and Chart-7) 
Correlation of serum osmolality and mode of presentation in DKA 
patients: 
In this study, 37 patients were having serum osmolality values less than 
320 mOsm/kg and among these 37 patients, only 3 patients were 
presented with mental confusion/ coma (8.1%).  13 patients were 
having serum osmolality values more than 320 mOsm/Kg and among 
these 13 patients, 11 patients were presented with mental confusion 
and coma (84.6%). This result shows that positive correlation 
between higher serum osmolality values and high incidence of mental 
confusion/ coma in DKA patients. (Table – 8 and Chart – 8)  
Outcome of the treatment: 
In 50 patients, 47 patients (94%) were completely recovered from DKA 
and 3(6%) patients were died due to complications. This result shows 
that the mortality rate was 6 %. (Table- 9 and Chart- 9) 
 
Correlation of serum bicarbonate level and mean duration of 
hospital stay in DKA patients: 
In our study, 31 patients were having their serum bicarbonate values in 
between 16-20 mEq/L , and  the mean duration of hospital stay in 
these patients was 9.8 days (p value= 0.054). 12 patients were having 
bicarbonate values in between 11-15 mEq /L, and the mean duration 
of hospital stay in these patients was 12.06 days (p  value = 0.004). In 
7 patients, serum bicarbonate values are ≤ 10 mEq/L and the mean 
duration of hospital stay in these patients is 14.2 days (p = 0.001, 
statistically significant). These results show that the mean duration of 
hospital stay was increased in patients with low bicarbonate values. 
(Table- 10 and Chart -10) 
Correlation of patient’s HbA1c values with mean duration hospital 
stay: 
In our study, 5 patients were having HbA1c values in between 6.5- 7.5 
and mean duration of hospital stay in these patients was10.02 days (p 
value= 0.504, not significant). In 9 patients, the HbA1c values were 
in between 7.6- 8.5, and mean duration of hospital stay in these 
patients was 10.2 days (p value = .482. not significant).  12 patients 
were having HbA1c values in between 8.6-9.5 and their mean 
duration of hospital stay was 10.1 days (p value =0.501, not 
significant). 24 patients were having their HbA1c values > 9.6 and 
their mean duration of hospital stay was 9.9 days (P value = 0.511, 
not significant). These results reveal that the HbA1c didn’t have the 
correlation with mean duration of hospital stay in DKA patients.  
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                                                     RESULTS 
Table: 1-   Age distribution in DKA patients  
s.no Patients age in 
years 
No of 
DKA 
patient
s 
Mean age 
in  
years 
Percentage 
(%) 
1 13- 30 7 16.2 14 
2 21-30 13 26.02 26 
3 31-40 11 33.14 22 
4 41-50 6 45.08 12 
5 51-60 8 54.04 16 
6 More than 60 5 68.20 10 
 Chart: 1 
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Table: 2 -     sex distribution in DKA patients 
S.no sex No of DKA patients Percentage 
(%) 
1 Male 36 72 
2 Female 14 28 
total  50  
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s.no 
Type of diabetes No of DKA 
patients 
Percentage 
1 Type 1 31 62 
2 Type2 19 38 
total  50  
 Table- 4 
S.no Duration of 
diabetes in 
years 
No of DKA 
patients 
Percentage (%) 
1 0-5 22 44 
2 6-10 14 28 
3 11-15 12 24 
4 >15 2 4 
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Table – 5 
S.no Presenting symptom/ sign No of DKA 
patients 
Percentage 
(%) 
1 Thirst/polyuria/ 
dehydration 
13 26 
 2 Mental confusion 11 22 
3 Nausea/vomiting 7 14 
4 Hypotension/cold 
extremities 
3 6 
5 Shortness of breath 2 4 
6 Abdominal pain/ 
discomfort 
3 6 
7 lethargy 3 6 
8 Palpitation/ tachycardia 2 4 
9 coma 2 4 
10 No symptoms 4 8 
 Total 50  
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Thirst, polyuria with dehydration, mental confusion and nausea, vomiting 
were identified in more patients. 
 
 
 
 
Table – 6 
13 
11 
7 
3 
3 
2 
2 
3 
2 
4 
presenting symptom/ sign 
thirst/ polyuria/ dehydration
(26%)
mental confusion (22%)
nausea/ vomiting (14%)
hypotension (6%)
abdominal pain (6%)
coma (4%)
palpitation/ tachcardia(4%)
lethargy (6%)
shortness of breath(4%)
no syptoms (8%)
S.no Precipitating cause No of 
DKA 
patient
s 
Percentage 
(%) 
1 Infection 17 34 
2 Insulin/ OAD omission 14 28 
3 Inadequate insulin 
administration 
7 14 
4 Infarction 2 4 
5 No cause identified 8 16 
6 newly diagnosed DM 
presenting with DKA 
2 4 
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Table -7  
S.no HbA1c level Number of DKA 
patients 
Percentage (%) 
1 6.5 -7.5 5 10 
2 7.6 -8.5 9 18 
3 8.6 – 9.5 12 24 
4 >9.6 24 48 
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Table - 8 
s.no Serum 
osmola
lity 
(m0sm/kg) 
No of DKA 
patients 
No of 
DKA 
patients 
with 
mental 
confusi
on/ 
coma 
Percentage 
(%) 
1 <320 37 3 8.1 
2 >320 13 11 84.6 
total  50 14  
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Table – 9  
S.no Outcome of the treatment No of DKA 
patients 
Percentage 
(%) 
1 Recovered 47 94 
 2 Death 3 6 
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During hospital treatment, among 50 DKA patients, 47 patients recovered 
completely and 3 patients died due to complications. 
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 Table – 10 
s.no Serum 
bicarbonate 
level in mEq/ 
L 
No of 
DKA 
patie
nts 
Mean 
duration 
of 
hospital 
stay 
P value 
1 16- 20 31 9.8 days 0.054 
2 11- 15 12 12.06 days 0.004 
3 < 10 7 14.2 days 0.001 
total  50   
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Table - 11 
s.no HbA1c 
level 
No of 
DK
A 
patie
nts 
Mean 
durati
on of 
hospit
al stay 
in 
days 
‘p’ 
va
lu
e 
Statistical 
signific
ant 
1 6.5 -7.5 5 10.02 0.504 Not 
signific
ant 
2 7.6 -8.5 9 10.2 0.482 Not 
9.8 
12.06 
14.2 
0
2
4
6
8
10
12
14
16
S.HCO3 16-20 mEq/l 11-15 mEq/l <10mEq/l
Mean duration of hospital stay in correlation 
with serum bicorbonate level 
signific
ant 
3 8.6 – 9.5 12 10.1 0.501 Not 
signific
ant 
4 >9.6 24 9.9 0.511 Not 
signific
ant 
total  50    
 
Chart – 11 
 
  
10.02 
10.2 
10.1 
9.9 
9.75
9.8
9.85
9.9
9.95
10
10.05
10.1
10.15
10.2
10.25
HbA1c level 6.5-7.5 7.6-8.5 8.6-9.5 >9.6
Mean duration of hospital stay in correlation 
with HbA1c level 
                       DISCUSSION 
AGE DISTRUBUTION: 
In this study, more incidence of Diabetic occurs in the 20 – 40 age 
groups in adult population. This finding was consistent with a 
study a conducted by Balasubramanyam A et al.  
SEX DISTRIBUTION: 
In our study, males were 36 and females were 14. Male: female 
ratio was 2.6: 1. It is comparable with studies done by Berhane 
Seyoum, MD University school of Medicine, Detroit. In his 
study, he observed that the male: female sex ratio was 2:1. 
INCIDENCE OF DKA IN CORRELATION WITH TYPE OF 
DIABETES: 
In our study, among these 50 patients, 31 (62%) were type 1 
diabetes and 19 (38 %) were type 2 diabetes. This result was 
correlating with studies conducted by Wachtel Tj et al.  Diabetic 
ketoacidosis was more common among the type 1 diabetics. 
 
CORRELATION OF DURATION OF THE DIABETES AND 
THE INCIDENCE OF DKA: 
In this study, the incidence of DKA was more in early period of 
diabetes (In 0-5 years duration of Diabetes, 22 patients 
developed DKA among 50 patients). This clearly showed that 
the incidence of DKA was not increasing in relation with 
increased duration of diabetes. 
PRESENTATION OF DKA: 
 In our study, thirst, polyuria with dehydration (26%), mental 
confusion (22%) and nausea / vomiting (14%) are the most 
common presentations in DKA. These findings were consistent 
with the findings in a study done by C Rajasoorya et al. 
PRECIPITATING CAUSES IN DKA: 
In this study, among the precipitating causes, infection accounts for 
about 34%, insulin/ drug omission accounts for about 14 %, and 
inadequate insulin administration accounts for about 7%. These 
results were comparable with results of studies done by matoo 
Vk, and Bonadio wa et al. 
CORRELATION OF DKA INCIDENCE WITH HbA1c LEVEL: 
In our study, among the 50 patients 24 (48%) patients were having 
the HbA1c level more than 9.6 % and 12 patients (24%) were 
having HbA1c level in between 8.6 – 9.5 %. This showed that 
incidence of diabetic ketoacidosis was higher in patients with 
high   HbA1c level.  This result was correlating with a study 
done by Ramaswamy Ganesh at Baylor college of Medicine, 
Houston. In his study, he observed that all the 21 patients were 
having high HbA1c values. 
SERUM OSMOLALITY AND DKA PRESENTATION –
CORRELATION: 
In our study, out of 50 patients , 37 patients were having serum 
osmolality values less than 320mOsm/kg and 13 patients were 
having more than 320 mOsm/ kg. Among these 37 patients, only 
2 (8.1%) were presented with mental confusion/coma but, but in 
second group, among 13 patients, 11 patients (84.6%) were 
presented with mental confusion / coma. This clearly indicates 
that the patient’s serum osmolality was strongly correlates with 
their mental state. These findings were similarly coincides with a 
study done by C Rajasoorya and his colleagues; among 33 DKA 
patients in Department of medicine, Alexander hospital, 
Singapore and references in the standard text book. 
OUTCOME OF THE DKA DURIGNG TREATMENT: 
In this study, out of 50 patients, 47 (94%) were cured and 3 (6%) 
patients died due diabetic ketoacidosis complications. The 
mortality rate was 6%. This result is consistent with findings in 
the various studies. Berhane Seyoum, MD, University school of 
Medicine, Detroit, did a study in 847 DKA patients; the 
mortality rate in his study was 6 %. 
CORRELATION OF SERUM BICORBONATE LEVEL AND 
MEAN DURATION OF HOSPITAL STAY: 
 In this study, out of 50 patients, 31 patients were having their 
serum bicarbonate level, in between 16-20 mEq/l and mean 
duration of hospital stay in these patient was 9.8 days ( p value = 
0.054; statistically not significant). twelve patients were having 
serum bicarbonate values in between 11-15 mEq/l  and the mean 
duration of hospital stay in these patients was 12.06 days ( p 
value = 0.004; statistically significant). Seven patients were 
having the serum bicarbonate values less than 10 mEq/l and the 
mean duration of hospital stay in these patients was 14.2 days (p 
value = 0.001; statistically significant). This results clearly 
shows, when the serum bicarbonate level decreases, the degree 
of metabolic acidosis also increases and affects the outcome of 
the DKA patients; these findings were coincides with references 
in the standard text books. 
HbA1c LEVEL AND MEAN DURATION OF HOSPITAL STAY- 
CORRELATION: 
In this study, the mean duration of hospital stay was almost equal in 
all groups with various HbA1c levels. The values are not 
statistically significant. These results show that HbA1c level 
didn’t have any correlation with the outcome of the DKA 
patients. 
 
 
 
 
 
 
                 LIMITATIONS OF THE STUDY 
1. In this study, urine acetone was used as a diagnostic 
method to detect ketoacidosis. Plasma ketone estimation 
was not done. 
2. Small number of population was taken as study subjects. 
3. Diabetic ketoacidosis patients were not followed after the 
study period. 
 
 
 
 
 
 
 
 
 
 
                     
 
                                    CONCLUSION 
1. Diabetic ketoacidosis incidence is more in 20-40 years                                     
age group in adult population. 
2. Diabetic ketoacidosis is more often occur in males 
compare to females. 
3 .The incidence of the DKA is more in Type 1 diabetic 
compare to type 2 diabetics. 
4 .Duration of diabetes doesn’t have any correlation with 
incidence of diabetic ketoacidosis. 
5. Thirst, polyuria with dehydration, mental confusion, and 
nausea/ vomiting are the common presentation this study. 
6. Infection, insulin/ drug omission, and inadequate insulin 
administration are more frequently noticed precipitating 
factors in this study. 
7. HbA1c level have a positive correlation with the incidence 
of DKA. 
8. Patient’s high serum osmolality value is strongly 
associated with their presentation of mental confusion/coma. 
9. The mortality rate in this study is 6 %. 
 
10. Patient’s low serum bicarbonate level is strongly 
associated   with their prolonged stay in the hospital. 
 
11. Patient’s HbA1c level doesn’t have any correlation with 
their stay in the hospital. 
 
                      
 
 
 
 
 
 
 
 
 
 
 
                                          
 
                                      PROFORMA 
NAME: 
AGE:  
SEX:  
ADDRESS: 
TYPE OF DIABETES: 
DURATION OF DIABETES:  
PRESENTATION: 
Nausea/ vomiting □                                 Mental confusion □ 
Thirst / polyuria □                                   Coma □  
Weight loss / weakness □                        without symptoms □ 
Abdominal pain □                                   Hypotension □ 
          PRECIPITATING CAUSE :   
In adequate insulin administration □ 
Poor patient compliance □ 
Infection □  
Infarction □  
No obvious precipitating cause □  
 
BIOCHEMICAL PROFILE :  
Random blood sugar: 
Blood Urea: 
Serum Creatinine: 
Serum electrolytes:  
Sodium:                
Potassium:  
Bicarbonate:                 
HbA1c level: 
Urine acetone:  
Serum osmolality:   
OUTCOME: 
Recovered □  
Death □  
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                                                                                              MASTER CHART 
S.N A S TYPE RBS UREA C NA K HCO
3 
HbA1C OSM UA D SYM P.F O 
1 
66 
F 
type 2 600 196 2.7 144 5.2 15.5 8.2 356.5 
P 
 20 mental confusion infection 
R 
2 36 M type1 543 60 1.3 149 3.8 9.6 9.9 338.9 P 1 coma subdural hematoma D 
3 29 M type1 466 52 1.2 139 4.3 17.2 8.4 322 P 5 mental confusion insulin omission R 
4 80 M type 2 455 71 1.4 151 5.4 19 9 351 P 30 coma no cause R 
5 29 M type1 322 77 1.2 139 4.8 18.5 9.2 303 P 5 nausea/vomiting insulin omission R 
6 49 F type2 445 54 1.8 134 4.7 18.1 6.8 310 P 6 thirst/ polyuria infection R 
7 
56 
M 
type2 356 43 1.1 129 5.2 16.4 7.4 301 
P 
13 
Hypotension& cold 
extremities infection 
R 
8 
48 
M 
type2 476 40 0.9 155 5.1 20 7.1 344 
P 
11 mental confusion drug omission 
R 
9 
23 
F 
type 1 487 34 0.8 126 5.6 14.8 8.9 308 
P 
5 abdominal pain  drug omission 
R 
10 
34 
M 
type1 478 50 0.8 131 4.5 9.2 9.2 298 
P 
13  dehydration insulin omission 
R 
11 58 M type2 390 45 0.7 154 5 18.4 11 338 P 10 nausea/vomiting infection R 
12 38 M type 1 376 32 0.9 126 5.4 15.6 10.2 303 P 15 acidotic  breathing no cause R 
13 18 M type 1 410 49 1.3 131 5.1 17.4 9.3 300.5 P 4  dehydration  newly diagnosed R 
14 
34 
F 
type 1 476 32 1.2 129 4.4 9.4 10 291 
P 
3 thirst/ polyuria drug omission 
R 
15 
57 
M 
type2 511 65 1.4 144 4 17.3 10.5 301.5 
P 
8  dehydration infection 
R 
16 
61 
M 
type2 466 43 1 144 4.6 12.4 7.8 288 
P 
11 no symptoms no cause 
R 
17 49 F type2 473 42 1.4 134 5.4 14.5 9.2 313 P 4 mental confusion infection R 
18 19 M type 1 398 32 1 148 5.1 18 9.6 324 P 4 mental confusion insulin omission D 
`19 33 F type 1 455 37 0.8 131 4.9 15 8.2 307 P 8  dehydration insulin omission R 
20 
36 
M 
type 1 490 35 1.1 137 3.5 9.5 10.1 300.5 
P 
11 mental confusion no cause 
R 
21 
27 
F 
type 1 481 33 1.2 134 2.9 15.1 8.5 315 
P 
5 acidotic breathing infection 
R 
22 
58 
M 
type2 394 35 1 131   14 9.1 291 
P 
11  dehydration drug omission 
R 
23 48 M type2 600 37 1.3 129 5.1 19 9.7 301.5 P 4  dehydration no cause R 
24 31 F type1 543 51 1.7 136 4.4 16.4 9 288 P 9 nausea/vomiting infection R 
25 
51 
M 
type2 466 71 1.9 143 4 10 10.2 313 
P 
4  dehydration infection 
R 
 
Sn A S TYPE RBS U Cr NA K HCO HbA1C OSM U.A D SYMPTOM P.F O 
26 
21 
M 
type 1 455 50 1 155 4.6 17 7.4 343 
P 
2 mental confusion insulin omission 
R 
27 
16 
M 
type 1 322 44 1.1 151 5.4 19 7.1 329 
P 
4 mental confusion infection 
R 
28 
36 
M 
type2 445 33 0.9 131 5.1 16.3 8.9 291 
P 
10  dehydration drug omission 
R 
29 
46 
F 
type2 356 32 0.7 134 4.9 18 9.2 301.5 
P 
3  lethargy inadequate insulin 
R 
30 
60 
M 
type2 476 32 1.2 126 3.5 19.2 11 288 
P 
8 thirst/ polyuria infection 
R 
31 
22 
M 
type 1 487 30 1 131 4.8 18 10.2 313 
P 
5 tachycardia  no cause 
R 
32 
28 
M 
type 1 478 29 0.9 144 3.8 21 9.3 327 
P 
6 mental confusion insulin omission 
R 
33 
20 
M 
type 1   78 2.1 155 4.3 9.6 8 344 
P 
3 mental confusion inadequate insulin 
R 
34 
33 
F 
type1 376 31 0.8 129 5.4 17 7.8 298 
P 
9  lethargy no cause 
R 
35 
43 
M 
type2 410 28 1.2 118 4.8 13 7.8 301 
P 
4 nausea/vomiting infection 
R 
36 
58 
M 
type2 476 25 0.8 129 4.7 17.2 8.2 308 
P 
12 hypotension infection 
R 
37 
18 
M 
type 1 511 65 1.2 144 5.2 18 9.9 318 
P 
1 dehydration no cause 
R 
38 
34 
M 
type 1 466 32 1.2 143 5.1 17.2 8.4 303 
P 
12 nausea/vomiting insulin omission 
R 
39 
16 
F 
type 1 473 75 2.3 152 5.6 19 9 345 
P 
3  dehydration newly diagnosed 
R 
40 
17 
M 
 type1  398 49 0.8 134 4.5 18.5 9.2 304 
P 
3  dehydration infection 
R 
41 
25 
F 
type 1 455 54 1.2 131 5 18.1 6.8 297 
P 
7 abdominal pain  infection 
R 
42 
31 
M 
type 1 490 76 2 134 5.4 16.4 7.4 309 
P 
9  lethargy infection 
R 
43 
28 
M 
type 1 481 40 2.9 126 5.1 20 7.1 301 
P 
5 tachycardia  inadequate insulin 
R 
44 
29 
F 
type 1 394 24 0.8 151 4.4 14.8 10.6 327 
P 
9 altered sensorium cerebral infarction 
D 
45 
20 
M 
type 1 480 55 2.6 152 4 19 9.2 306 
P 
4 mental confusion insulin omission 
R 
46 
57 
M 
type2 511 76 1.7 129 4.6 18.4 11 291 
P 
12 hypotension infection 
R 
 47 
63 
F 
type2 385 100 2 136 5.4 9.8 10.2 301.5 
P 
13 no symptoms drug omission 
R 
48 
32 
M 
type 1 411 23 0.8 131 5.1 17.4 9.3 288 
P 
12  lethargy insulin omission 
R 
49 
21 
M 
type 1 470 71 1.9 126 4.9 13.2 8 313 
P 
4  dehydration inadequate insulin 
R 
50 
20 
M 
type 1 385 34 0.8 131 3.5 17.3 9.5 306 
P 
6 no symptoms infection 
R 
 
SN- SERIAL NUMBER                                                                               R- RECOVERED 
A- AGE                                                                                                        D- DEATH 
S- SEX 
M-MALE 
F-FEMALE 
RBS- RANDOM BLOOD SUGAR 
U-UREA 
CR-CREATININE 
NA-SODIUM 
K-POTASSIUM 
HCO-BICORBONATE 
OSM-SERUM OSMOLALITY 
U.A-URINE ACETONE 
D-DURATION OF DIABETES 
PF-PRECIPITATING FACTOR 
O-OUTCOME 
  
  
